Gilead Sciences says it still plans to supply its twice-yearly injection for preventing HIV infection in low-income countries ...

A new, highly transmissible COVID subvariant has been detected in California — heightening the risk of a summer wave as ...

Stealth received the FDA's so-called 'complete response letter' after a 16.5-month review, during which the FDA extended its ...

Cucumbers grown by Florida-based Bedner Growers have been recalled, triggering a series of further recalls from stores like ...

Spun off from Novartis in 2019, Alcon is betting on new product launches to accelerate sales growth in the second half of ...

The U.S. Food and Drug Administration has asked for a resubmission of Stealth BioTherapeutics' marketing application for its ...

“Reported cases were rare but sometimes serious, with patients experiencing widespread, severe itching that required medical ...

ClearSight, a leading provider of advanced vision correction solutions, is now offering the PanOptix® Trifocal Intraocular ...

Daiichi Sankyo, along with partner Merck & Co., has pulled an FDA approval filing for an antibody-drug conjugate (ADC) cancer ...

Instead, Stealth submitted a new drug application (NDA) seeking approval of elamipretide and the FDA issued its ...

Instead of approving Stealth BioTherapeutics' drug for Barth syndrome, the FDA withheld its endorsement, but decided it may ...

The U.S. Food and Drug Administration cleared the first in vitro diagnostic device that tests blood to aid in diagnosing ...